- The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
-
Park JY
- KMID: 2465198
- J Gynecol Oncol.
- 2020 Jan;31(1):e40.
- doi: 10.3802/jgo.2020.31.e40
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology, October 10th to 12th, 2019
-
Charoenkwan K, Wilailak S
- KMID: 2465197
- J Gynecol Oncol.
- 2020 Jan;31(1):e38.
- doi: 10.3802/jgo.2020.31.e38
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The basic principles of oncologic surgery during minimally invasive radical hysterectomy
-
Köhler C, Schneider A, Marnitz S, Plaikner A
- KMID: 2465196
- J Gynecol Oncol.
- 2020 Jan;31(1):e33.
- doi: 10.3802/jgo.2020.31.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- How to predict treatment failure in frail patients with advanced epithelial ovarian cancer: strategies to personalize surgical effort
-
Fotopoulou C
- KMID: 2465193
- J Gynecol Oncol.
- 2020 Jan;31(1):e26.
- doi: 10.3802/jgo.2020.31.e26
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely
-
Nishikimi , Tate S, Kato K, Matsuoka A, Shozu M
- KMID: 2500402
- J Gynecol Oncol.
- 2020 Jan;31(1):e3.
- doi: 10.3802/jgo.2020.31.e3
Objective: This study was performed to examine the safety of bowel resection and upper abdominal surgery in patients with advanced ovarian cancer performed by gynecologic oncologists after training in a... -
- CITED
-
- Close
- SHARE
-
- Close
- A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a National Immunization Program
-
Garland S
- KMID: 2465195
- J Gynecol Oncol.
- 2020 Jan;31(1):e32.
- doi: 10.3802/jgo.2020.31.e32
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
-
Kong TW, Kim M, Kim YH, Kim YB, Kim J, Kim JW, Park MH, Park JH, Rhee JH, Lim MC, Hong JS
- KMID: 2465194
- J Gynecol Oncol.
- 2020 Jan;31(1):e31.
- doi: 10.3802/jgo.2020.31.e31
Based on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers
-
Lee JH, Lee JH, Jo KW, Huh JW, Oh YM, Lee JS
- KMID: 2500409
- J Gynecol Oncol.
- 2020 Jan;31(1):e10.
- doi: 10.3802/jgo.2020.31.e10
Objectives: Two randomized, controlled studies comparing outcomes in patients treated with direct oral anticoagulants or low-molecular weight heparin for cancer-associated venous thromboembolism (VTE) have previously been performed. However, gynecologic cancers... -
- CITED
-
- Close
- SHARE
-
- Close
- The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy
-
Aslan K, Meydanli M, Oz M, Tohma YA, Haberal A, Ayhan A
- KMID: 2500400
- J Gynecol Oncol.
- 2020 Jan;31(1):e1.
- doi: 10.3802/jgo.2020.31.e1
Objective: The aim of this study was to determine the prognostic value of lymph node ratio (LNR) in women with 2018 International Federation of Gynecology and Obstetrics stage IIIC cervical... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
-
Lai CH, Vallikad E, Lin H, Yang LY, Jung SM, Liu HE, Ou YC, Chou HH, Lin CT, Huang HJ, Huang KG, Qiu J, Hung YC, Wu TI, Chang WY, Tan KT, Lin CY, Chao A, Chang CJ
- KMID: 2500404
- J Gynecol Oncol.
- 2020 Jan;31(1):e5.
- doi: 10.3802/jgo.2020.31.e5
Objectives: An Asian Gynecologic Oncology Group phase III randomized trial was conducted to determine whether maintenance chemotherapy could improve progression-free survival (PFS) in stages III/IV ovarian cancer. Methods: Between 2007 and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy:a retrospective study
-
Xiao Y, Cheng H, Wang L, Yu X
- KMID: 2500401
- J Gynecol Oncol.
- 2020 Jan;31(1):e2.
- doi: 10.3802/jgo.2020.31.e2
Objective: To observe the safety and short-term efficacy of apatinib in the treatment of recurrent, metastatic cervical cancer in patients who have already received more than two kinds of comprehensive... -
- CITED
-
- Close
- SHARE
-
- Close
- Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer
-
Kong TW, Son JH, Paek J, Chang SJ, Ryu HS
- KMID: 2500406
- J Gynecol Oncol.
- 2020 Jan;31(1):e7.
- doi: 10.3802/jgo.2020.31.e7
Objective: To evaluate oncologic outcomes of minimally invasive radical hysterectomy (RH) in early cervical cancer before and after the application of parametrial invasion (PMI) criterion on magnetic resonance imaging (MRI)... -
- CITED
-
- Close
- SHARE
-
- Close
- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience
-
Amadio G, Marchetti , Villani ER, Fusco D, Stollagli , Bottoni C, Distefano , Colloca G, Scambia G, Fagotti A
- KMID: 2500405
- J Gynecol Oncol.
- 2020 Jan;31(1):e6.
- doi: 10.3802/jgo.2020.31.e6
Objective: Bevacizumab maintenance following platinum-based chemotherapy is an effective treatment for epithelial ovarian cancer (EOC), both in primary and recurrent disease. Our aim was to identify criteria to select elderly... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study
-
Li H, Pang Y, Cheng X
- KMID: 2500407
- J Gynecol Oncol.
- 2020 Jan;31(1):e8.
- doi: 10.3802/jgo.2020.31.e8
Objective: The purpose of this study was to analyze the impact of surgery of primary sites on stage IVB cervical cancer patients from a population-based database, the Surveillance, Epidemiology and... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
-
Liu YL, Filippova OT, Zhou Q, Iasonos A, Chi DS, Zivanovic O, Sonoda Y, Gardner GJ, Broach VA, O'Cearbhaill RE, Konner JA, Aghajanian C, Long Roche K, Tew WP
- KMID: 2465191
- J Gynecol Oncol.
- 2020 Jan;31(1):e17.
- doi: 10.3802/jgo.2020.31.e17
OBJECTIVE: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) confers similar outcomes as primary debulking surgery and chemotherapy. Little is known about patients who receive NACT but do not... -
- CITED
-
- Close
- SHARE
-
- Close
- An optimized BRCA1/2 next-generationsequencing for different clinical sample types
-
Kim Y, Cho CH, Ha JS, Kim DH, Kwon SY, Oh SC, Lee KA
- KMID: 2500408
- J Gynecol Oncol.
- 2020 Jan;31(1):e9.
- doi: 10.3802/jgo.2020.31.e9
Objective: A simultaneous detection of germline and somatic mutations in ovarian cancer (OC) using tumor materials is considered to be cost-effective for BRCA1/2 testing. However, there are limited studies of... -
- CITED
-
- Close
- SHARE
-
- Close
- Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study
-
Seong J, Ryou S, Yoo M, Lee J, Kim K, Jee Y, Cho CH, Kim SM, Hong SR, Jeong DH, Lee WC, Park JS, Kim TJ, Kee MK
- KMID: 2500403
- J Gynecol Oncol.
- 2020 Jan;31(1):e4.
- doi: 10.3802/jgo.2020.31.e4
Objectives: Since 2007, human papillomavirus (HPV) vaccines have been administered for the prevention of cervical cancer in Korea. We investigated the status of HPV vaccination among HPV-infected adult women with... -
- CITED
-
- Close
- SHARE
-
- Close
